Posted in Job News, Mobile news, News
One of the worlds leading pharmaceutical companies, a business renowned for providing innovative, effective medicines for important areas of healthcare is recruiting for a Director, Diagnostic Expert to join them in Cambridge.
In this role you’ll be empowered to deliver all scientific, technical, clinical, financial, commercial and partnering aspects needed to implement an effective diagnostic strategy.
Your core accountabilities in this role would be:
- Implementing diagnostic development strategies within the product teams to meet the needs of patients, payers and physicians
- Obtaining and managing strategic investment to enable companion diagnostic development for the product teams
- Delivering expert advice on strategic direction for PHC approaches and companion diagnostic development
This client is seeking someone with a solid reputation in their PHC field and Oncology, ideally something you can evidence through your published work.
Posted in Job News, News
Jim Gleeson is recruiting for a Clinical Science Director to join a successful and expanding international pharmaceutical company at their offices in London on a permanent basis.
Responsibilities for this role include establishing and evaluating a development project strategy and clinical development plan in line with corporate objectives. You will also be expected to contribute towards the development of target product profiles and translations research plans.
To apply for this position you should have significant oncology research experience, strong clinical trials experience and proven knowledge of ICH-GCP, GMP and other regulatory requirements within the EU and US.
Posted in Job News, News
Hendre Moolman is recruiting for a Brand Manager (Oncology) to join a large pharmaceutical company based at their offices in Hertfordshire on a permanent basis.
Your main responsibilities will include acting as a brand champion, evolving and implement the brand strategy, and launching new products in the UK & Ireland.
If you have experience launching oncology products, experience with local market access activities and are a strong team player, then this is a good opportunity to join a multinational company in an exciting field.
Posted in Featured Jobs, News
As reported by Cancer Research UK, their Drug Development Office has announced that they will be running the Phase II clinical trial of an inherited breast and ovarian cancer drug.
The clinical trial will be led by The Sir Bobby Robson Cancer Trials Research Centre, Newcastle University and The Newcastle upon Tyne Hospitals HHS Foundation as well as many other cancer care organisations.
The drug, which is called Rucaparib and will be taken in tablet form by outpatients with advanced breast or ovarian cancer. The new drug belongs to a class of drugs which are known as PARP inhibitors which have shown promising results so far. These patients will take the tablet at home for 21 days and will only be required to come into hospital for check ups and tests.
The aim of the clinical trial will be to set the dosing schedule for the drug and to analyse the effectiveness of the drug for the treatment of advanced breast and ovarian cancer.
Speaking of the new drug, Professor Ruth Plummer, the trial’s chief investigator, at the Northern Institute for Cancer Research, at Newcastle University, said: “We’re seeing encouraging results in women with breast or ovarian cancer treated with PARP inhibitors. It’s great news that we’re able to run a trial of this exciting drug as a tablet which will be a much more convenient and comfortable way to receive the treatment.
“Patients will be able to take a tablet at home – which will mean they can go to work or stay at home with their families, instead of spending long periods of time at hospital with the discomfort of receiving the drug through a drip.”
Click here to search our oncology jobs now.